+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Tumor Screening Market - Global Forecast 2026-2032- Product Image
Canine Tumor Screening Market - Global Forecast 2026-2032- Product Image
Sale

Canine Tumor Screening Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6149296
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Tumor Screening Market is projected to reach USD 223.76 Million in 2026. It is expected to continue growing at a CAGR of 8.34%, reaching USD 360.25 Million by 2032.

Canine Tumor Screening: Executive Summary

Canine tumor screening encompasses veterinary approaches used to identify possible neoplastic disease before or during clinical evaluation. The field includes physical examination, imaging, cytology, histopathology, hematology, molecular assays, and emerging liquid-biopsy approaches. Screening decisions are shaped by the dog’s age, breed, symptoms, inherited risk, tumor type, and the availability of veterinary expertise. Because screening is not equivalent to diagnosis, abnormal findings generally require confirmatory testing and clinical interpretation.

Earlier Detection Is Reshaping Veterinary Oncology

The landscape is shifting from symptom-led investigation toward more structured risk assessment and earlier diagnostic workups. Greater owner awareness, longer companion-animal lifespans, advances in veterinary imaging, and improved access to specialty care are increasing attention to timely tumor evaluation. At the same time, clinicians must manage false positives, incidental findings, invasive sampling, cost sensitivity, and differences in diagnostic capacity across regions. Evidence-based protocols that connect screening with confirmatory pathology and treatment planning are therefore increasingly important.

Artificial Intelligence Supports Triage, Imaging, and Decision-Making

Artificial intelligence can assist canine tumor screening by highlighting suspicious patterns in radiographs, ultrasound, computed tomography, magnetic resonance imaging, cytology, and digital pathology. It may also support record review, risk stratification, workflow prioritization, and integration of clinical and laboratory data. These applications remain dependent on representative training data, external validation, transparent performance measures, and veterinarian oversight. Bias linked to breed, age, image quality, disease prevalence, and practice setting can reduce reliability, so AI should complement rather than replace clinical judgment and confirmatory diagnostics.

Regional Conditions Shape Access to Canine Tumor Screening

North America generally benefits from established specialty veterinary networks, advanced imaging, referral oncology, and relatively broad access to laboratory services, although affordability and rural access remain concerns. Europe combines strong academic veterinary centers with varied national reimbursement, regulatory, and diagnostic pathways; the European Union also reflects differences among member states. Asia-Pacific includes highly advanced urban markets alongside areas with limited specialty capacity, while adoption is influenced by companion-animal ownership trends and uneven infrastructure. Latin America is characterized by growing veterinary capability but unequal access to pathology, imaging, and oncology referral. In the Middle East, investment in companion-animal services is developing alongside substantial variation between countries. Africa faces pronounced differences in laboratory availability, specialist coverage, and geographic access, making practical, scalable screening pathways particularly relevant.

International Groups Influence Standards, Access, and Collaboration

ASEAN markets show varied veterinary infrastructure and regulatory environments, with major opportunities for shared training, laboratory networks, and regional referral pathways. BRICS members span diverse disease burdens, healthcare systems, and research capabilities, making harmonized protocols and affordable diagnostics important priorities. The European Union can support cross-border evidence development and technical alignment, while the G7 provides strong research, specialty-care, and data-governance capacity but still faces cost and access challenges. GCC countries are developing advanced private and specialty veterinary services, with demand shaped by urbanization and imported expertise. NATO members are not a uniform veterinary market, yet their broad scientific and institutional connections can facilitate collaboration in diagnostic standards, biosafety, and professional education.

Country-Level Priorities Reflect Distinct Veterinary Systems

Australia combines advanced veterinary education with geographic dispersion that complicates specialist access. Brazil and Mexico have expanding companion-animal sectors alongside regional differences in diagnostic availability. Canada and the United States possess extensive referral and laboratory capabilities, though affordability and rural coverage remain important considerations. China, India, Japan, and South Korea are experiencing evolving companion-animal care environments with substantial variation between metropolitan and nonmetropolitan services. France, Germany, Italy, Spain, and the United Kingdom have established veterinary institutions, but screening pathways, reimbursement practices, and access to specialty diagnostics differ. Russia’s capabilities vary by location, with centralized urban resources contrasting with broader access constraints. Across these countries, clinician training, pathology capacity, quality assurance, and owner communication are central to dependable screening.

Prioritize Validated, Accessible, and Clinically Integrated Screening

Industry leaders should define screening pathways around specific clinical questions rather than treating every test as universally appropriate. They should validate assays and AI tools across breeds, ages, tumor types, and practice settings; publish sensitivity, specificity, and uncertainty measures; and link positive screens to timely confirmatory diagnostics. Investment should focus on interoperable records, digital pathology, laboratory quality systems, and training for general practitioners and technicians. Services should also use transparent consent, clear communication of incidental findings, and tiered options that reflect owner budgets. Regional partnerships, referral networks, and continuing education can help reduce geographic disparities while maintaining veterinary oversight.

Methodology for a Reliable Canine Tumor Screening Assessment

A robust assessment should combine peer-reviewed veterinary oncology literature, clinical guidelines, diagnostic-validation studies, regulatory materials, laboratory standards, and evidence from veterinary hospitals and practices. Findings should be organized by screening modality, tumor presentation, patient risk profile, clinical setting, and geography. The review should distinguish screening, diagnostic confirmation, staging, and monitoring, while evaluating test performance, sample requirements, turnaround time, safety, usability, and implementation barriers. Regional, group, and country comparisons should be interpreted qualitatively where systems, reporting practices, and evidence availability are not directly comparable. AI applications require separate assessment of dataset provenance, validation design, explainability, and post-deployment monitoring.

Clinical Value Depends on Evidence, Access, and Responsible Interpretation

Canine tumor screening is progressing toward earlier, more data-informed evaluation, supported by advances in imaging, pathology, molecular testing, and artificial intelligence. Its practical value will depend less on isolated technologies than on validated workflows that connect risk assessment, screening, confirmation, and treatment decisions. Differences across regions, international groups, and countries make adaptable implementation essential. Leaders who combine scientific rigor with affordability, quality assurance, clinician training, and clear owner communication will be best positioned to improve the consistency and usefulness of canine cancer detection.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Canine Tumor Screening Market, by Test Type
7.1. Introduction
7.2. Cytology
7.2.1. Conventional Cytology
7.2.2. Digital Cytology
7.3. Histopathology
7.3.1. Histochemical Staining
7.3.2. Immunohistochemistry
7.4. Imaging
7.4.1. CT
7.4.2. MRI
7.4.3. Ultrasound
7.4.4. X-Ray
7.5. Molecular Diagnostics
7.5.1. Next Generation Sequencing
7.5.2. PCR Assays
8. Canine Tumor Screening Market, by Tumor Type
8.1. Introduction
8.2. Bone Tumor
8.2.1. Chondrosarcoma
8.2.2. Osteosarcoma
8.3. Hematopoietic Tumor
8.3.1. Histiocytic Sarcoma
8.3.2. Leukemia
8.3.3. Lymphoma
8.4. Mammary Tumor
8.4.1. Benign
8.4.2. Malignant
8.5. Oral Tumor
8.5.1. Epulis
8.5.2. Melanoma
8.5.3. Squamous Cell Carcinoma
8.6. Skin Tumor
8.6.1. Mast Cell Tumor
8.6.2. Melanoma
8.6.3. Squamous Cell Carcinoma
9. Canine Tumor Screening Market, by Sample Type
9.1. Introduction
9.2. Blood Based
9.2.1. Plasma
9.2.2. Whole Blood
9.3. Tissue Based
9.3.1. Formalin Fixed Paraffin Embedded
9.3.2. Fresh Tissue
9.4. Urine Based
9.4.1. Sediment
9.4.2. Whole Urine
10. Canine Tumor Screening Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratory
10.3. Research Institute
10.4. Veterinary Clinic
10.5. Veterinary Hospital
11. Canine Tumor Screening Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Sales
11.4. Retail Pharmacies
11.5. Third Party Distributors
11.5.1. National Distributors
11.5.2. Regional Distributors
12. Canine Tumor Screening Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Canine Tumor Screening Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Canine Tumor Screening Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AB Science
16.2. AniCon Labor GmbH
16.3. Anivive Lifesciences
16.4. Antech Diagnostics Inc
16.5. Biomerieux SA
16.6. CANCAN DIAGNOSTICS
16.7. ELIAS Animal Health
16.8. Embark Veterinary Inc
16.9. FidoCure
16.10. Gold Standard Diagnostics
16.11. Heska Corporation
16.12. IDEXX Laboratories Inc
16.13. ImpriMed
16.14. Neogen Corporation
16.15. Oncotect
16.16. Oxford BioDynamics
16.17. PetDx
16.18. Qbiotics Group Ltd
16.19. Regeneus Ltd
16.20. Scan Veterinary Diagnostics
16.21. SignalPET
16.22. VetDC Inc
16.23. Virbac
16.24. VolitionRx Limited
16.25. Zoetis Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Canine Tumor Screening Market, Years Considered for the Study
FIGURE 2. Global Canine Tumor Screening Market, Research Design
FIGURE 3. Global Canine Tumor Screening Market, Research Framework
FIGURE 4. Global Canine Tumor Screening Market, Data Triangulation
FIGURE 5. Global Canine Tumor Screening Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Canine Tumor Screening Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Canine Tumor Screening Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Canine Tumor Screening Market Size, by Tumor Type, 2025 vs 2032 (%)
FIGURE 9. Global Canine Tumor Screening Market Size, by Tumor Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Canine Tumor Screening Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Canine Tumor Screening Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Canine Tumor Screening Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Canine Tumor Screening Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Canine Tumor Screening Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Canine Tumor Screening Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Canine Tumor Screening Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Canine Tumor Screening Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Canine Tumor Screening Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Canine Tumor Screening Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Canine Tumor Screening Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Canine Tumor Screening Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Canine Tumor Screening Market Segmentation & Coverage
TABLE 2. Global Canine Tumor Screening Market Size, 2017-2032 (USD Million)
TABLE 3. Global Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Cytology Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cytology Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cytology Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Conventional Cytology Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Conventional Cytology Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Conventional Cytology Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Digital Cytology Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Digital Cytology Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Digital Cytology Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Histopathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Histopathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Histopathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Histochemical Staining Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Histochemical Staining Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Histochemical Staining Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Immunohistochemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Immunohistochemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Immunohistochemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global X-Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global X-Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global X-Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global PCR Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global PCR Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global PCR Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 47. Global Bone Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Bone Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Bone Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Chondrosarcoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Chondrosarcoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Chondrosarcoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Osteosarcoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Osteosarcoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Osteosarcoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hematopoietic Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hematopoietic Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hematopoietic Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Histiocytic Sarcoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Histiocytic Sarcoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Histiocytic Sarcoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Leukemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Leukemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Leukemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Lymphoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Lymphoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Lymphoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Mammary Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Mammary Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Mammary Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Benign Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Benign Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Benign Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Malignant Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Malignant Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Malignant Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Oral Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Oral Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Oral Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Epulis Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Epulis Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Epulis Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Melanoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Melanoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Melanoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Squamous Cell Carcinoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Squamous Cell Carcinoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Squamous Cell Carcinoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Skin Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Skin Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Skin Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Mast Cell Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Mast Cell Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Mast Cell Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Melanoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Melanoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Melanoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Squamous Cell Carcinoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Squamous Cell Carcinoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Squamous Cell Carcinoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 102. Global Blood Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Blood Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Blood Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Tissue Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Tissue Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Tissue Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Formalin Fixed Paraffin Embedded Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Formalin Fixed Paraffin Embedded Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Formalin Fixed Paraffin Embedded Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Fresh Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Fresh Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Fresh Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Urine Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Urine Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Urine Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Sediment Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Sediment Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Sediment Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Whole Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Whole Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Whole Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Global Diagnostic Laboratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Diagnostic Laboratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Diagnostic Laboratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Research Institute Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Research Institute Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Research Institute Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Veterinary Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Veterinary Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Veterinary Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Veterinary Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Veterinary Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Veterinary Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Third Party Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Third Party Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Third Party Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global National Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global National Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global National Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Regional Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Regional Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Regional Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 181. North America Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. North America Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 183. North America Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 184. North America Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 185. North America Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 186. North America Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 187. North America Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 188. North America Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 189. North America Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 190. North America Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 191. North America Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 192. North America Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 193. North America Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 194. North America Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 195. North America Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 196. North America Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 197. North America Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. North America Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. North America Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 200. Latin America Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Latin America Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 202. Latin America Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 203. Latin America Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 204. Latin America Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 205. Latin America Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 206. Latin America Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 207. Latin America Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 208. Latin America Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 209. Latin America Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 210. Latin America Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 211. Latin America Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 212. Latin America Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. Latin America Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 214. Latin America Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 215. Latin America Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 216. Latin America Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Latin America Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Latin America Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 219. Europe Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Europe Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 221. Europe Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 222. Europe Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 223. Europe Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 224. Europe Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 225. Europe Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 226. Europe Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 227. Europe Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 228. Europe Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 229. Europe Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 230. Europe Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 231. Europe Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 232. Europe Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 233. Europe Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 234. Europe Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 235. Europe Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Europe Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Europe Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 238. Middle East Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 239. Middle East Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 240. Middle East Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 241. Middle East Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 242. Middle East Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 243. Middle East Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 244. Middle East Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 245. Middle East Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 246. Middle East Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 247. Middle East Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 248. Middle East Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 249. Middle East Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 250. Middle East Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 251. Middle East Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 252. Middle East Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 253. Middle East Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 254. Middle East Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Middle East Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Middle East Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 257. Africa Canine Tumor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 258. Africa Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 259. Africa Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 260. Africa Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 261. Africa Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 262. Africa Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 263. Africa Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 264. Africa Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 265. Africa Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 266. Africa Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 267. Africa Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 268. Africa Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 269. Africa Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 270. Africa Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 271. Africa Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 272. Africa Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 273. Africa Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Africa Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Africa Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 276. Global Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. ASEAN Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. ASEAN Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 279. ASEAN Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 280. ASEAN Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 281. ASEAN Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 282. ASEAN Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 283. ASEAN Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 284. ASEAN Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 285. ASEAN Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 286. ASEAN Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 287. ASEAN Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 288. ASEAN Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 289. ASEAN Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 290. ASEAN Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 291. ASEAN Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 292. ASEAN Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 293. ASEAN Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. ASEAN Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. ASEAN Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 296. GCC Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. GCC Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 298. GCC Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 299. GCC Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 300. GCC Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 301. GCC Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 302. GCC Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 303. GCC Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 304. GCC Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 305. GCC Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 306. GCC Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 307. GCC Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 308. GCC Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. GCC Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 310. GCC Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 311. GCC Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 312. GCC Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. GCC Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. GCC Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 315. European Union Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. European Union Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 317. European Union Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 318. European Union Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 319. European Union Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 320. European Union Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 321. European Union Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 322. European Union Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 323. European Union Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 324. European Union Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 325. European Union Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 326. European Union Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 327. European Union Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 328. European Union Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 329. European Union Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 330. European Union Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 331. European Union Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. European Union Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 333. European Union Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 334. BRICS Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 335. BRICS Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 336. BRICS Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 337. BRICS Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 338. BRICS Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 339. BRICS Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 340. BRICS Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 341. BRICS Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 342. BRICS Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 343. BRICS Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 344. BRICS Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 345. BRICS Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Million)
TABLE 346. BRICS Canine Tumor Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 347. BRICS Canine Tumor Screening Market Size, by Blood Based, 2017-2032 (USD Million)
TABLE 348. BRICS Canine Tumor Screening Market Size, by Tissue Based, 2017-2032 (USD Million)
TABLE 349. BRICS Canine Tumor Screening Market Size, by Urine Based, 2017-2032 (USD Million)
TABLE 350. BRICS Canine Tumor Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 351. BRICS Canine Tumor Screening Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 352. BRICS Canine Tumor Screening Market Size, by Third Party Distributors, 2017-2032 (USD Million)
TABLE 353. G7 Canine Tumor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 354. G7 Canine Tumor Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 355. G7 Canine Tumor Screening Market Size, by Cytology, 2017-2032 (USD Million)
TABLE 356. G7 Canine Tumor Screening Market Size, by Histopathology, 2017-2032 (USD Million)
TABLE 357. G7 Canine Tumor Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 358. G7 Canine Tumor Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 359. G7 Canine Tumor Screening Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 360. G7 Canine Tumor Screening Market Size, by Bone Tumor, 2017-2032 (USD Million)
TABLE 361. G7 Canine Tumor Screening Market Size, by Hematopoietic Tumor, 2017-2032 (USD Million)
TABLE 362. G7 Canine Tumor Screening Market Size, by Mammary Tumor, 2017-2032 (USD Million)
TABLE 363. G7 Canine Tumor Screening Market Size, by Oral Tumor, 2017-2032 (USD Million)
TABLE 364. G7 Canine Tumor Screening Market Size, by Skin Tumor, 2017-2032 (USD Mil

Companies Mentioned

  • AB Science
  • AniCon Labor GmbH
  • Anivive Lifesciences
  • Antech Diagnostics Inc
  • Biomerieux SA
  • CANCAN DIAGNOSTICS
  • ELIAS Animal Health
  • Embark Veterinary Inc
  • FidoCure
  • Gold Standard Diagnostics
  • Heska Corporation
  • IDEXX Laboratories Inc
  • ImpriMed
  • Neogen Corporation
  • Oncotect
  • Oxford BioDynamics
  • PetDx
  • Qbiotics Group Ltd
  • Regeneus Ltd
  • Scan Veterinary Diagnostics
  • SignalPET
  • VetDC Inc
  • Virbac
  • VolitionRx Limited
  • Zoetis Inc

Related Topics

Related Reports

Canine Cancer Screening Market - Global Forecast 2026-2032 - Product Image

Canine Cancer Screening Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Veterinary Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 111 Pages
  • Global
From
Canine Parvovirus Detection Kit Market - Global Forecast 2026-2032 - Product Image

Canine Parvovirus Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Veterinary Stereotactic Radiosurgery Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Stereotactic Radiosurgery Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 117 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.